Join us today at #VEITH2019 as we discuss Lutonix clinical safety data and the #Venovo Vernacular 24-month results. Click here for the full Thursday agenda: bddy.me/2KWFOO3

The New Jersey-based company says its COVID-19 test could deliver results to hospitals in as few as two hours ti.me/3d8nca0

One of our field service techs visited a cancer center in his storm trooper costume (with permission from the facility) to bring some cheer to patients and staff. #maythe4thbewithyou

Now available: VAM/SVS WavelinQ™ EndoAVF Symposium! Dr. Berland and Dr. Mueller discuss their real-world experience with WavelinQ™ EndoAVF System. bddy.me/3dyWaHY

We are honored to be among this year’s nominees by the Galien Foundation, as one of the 18 most innovative medical devices in 2020. massdevice.com/the-18-most-in…

BD is honored to be recognized among this year’s nominees for Best Medical Technology award by the The Galien Foundation: bddy.me/31RVAB9

What a year 2020 has been! I am proud of all of our associates who adjusted and showed an amount of resilience this year that is truly commendable. Despite challenges, we still executed 11 launches this year! Great job! Thank you for all of your efforts.

TAMPA BAY SOUNDS NICE THIS TIME OF YEAR 🌴

Welcome to our BD – Peripheral Intervention Twitter! We are excited to provide you the latest updates on trainings, webinars, innovative products, and much more!

Building greater awareness about #PAD during #NationalDiabetesMonth requires a united effort. Our physician finder tool makes it easy for #PAD patients to discover physicians in their area. Join the growing network: bit.ly/30sODor #BDemployee bit.ly/3D3i0Rx

GOODNIGHT 👌🏼

"This therapy can potentially redefine how we treat glioblastoma patients whose cancer came back," said Dr. Chen of U of M Neurosurgery Read more in this Medscape article summarizing Dr. Chen's recent publication with perspectives from William Curry ow.ly/bewr50J3fig

This week’s GammaTile by GT Medical Technologies, Inc. training class includes 9 new hires on the commercial team! We’re excited to add such talented and focused employees to #TeamGT to advance our purpose of Improving the Lives of Patients with Brain Tumors! #GammaTile

It began as a conversation between friends discussing unmet patient needs. Today, Penumbra is a global leader in helping patients worldwide. Watch how it started and how our commitment to #innovation is transforming #stroke intervention. #PenumbraProud bit.ly/3yFkNQ7

US HCPs: Introducing the newest addition to the RED family, #RED43! Rx only. For risk info: bit.ly/2BYj7Yj Clinical results may vary

US HCPs: Delivering on our commitment to innovation: Two differentiated technologies designed for optimal stroke care: #BMX and #RED. Rx only. For risk info: bit.ly/2BYj7Yj Clinical results may vary.

US HCPs: We are proud to introduce RED 72 with SENDit Technology, our latest technology in stroke care, designed for simplicity and ease of delivery. Learn more here: penumbrainc.com/red-72-sendit/ Rx only. For risk info: bit.ly/2BYj7Yj Clinical results may vary.

Join us on June 27th for a webinar with Dr. Sudhakar R. Satti, MD, FAHA and Dr. Michael Abraham as they explore the capabilities of RED72 with SENDit Technology and share expert insights on its clinical applications

US HCPs: Excellent case showcasing the speed and power of our RED 72 + SENDit Technology from Dr. Jeff Beecher. First-pass, TICI 3 result in approx. 7 minutes. #SENDit Rx only. For risk info: bit.ly/2BYj7Yj Clinical results may vary.